RESEARCH ARTICLE
Nobel Med 2021; 17(2): 111-117

LACTATE–ALBUMIN DIFFERENCE IN MEDICAL AND SURGICAL INTENSIVE CARE UNITS

Pelin Corman Dinçer, Mustafa Kemal Arslantaş, Gülbin Töre Altun, Reyhan Arslantaş, Alper Kararmaz
ABSTRACT
Objective: Sequential Organ Failure Assessment (SOFA) score, lactate, and lactate-albumin difference values obtained at admission to surgical and medical intensive care units are evaluated for cutoff values and predictive significance on mortality.

Material and Method: Data between 2001 and 2012 were extracted from MIMIC–III database. Adult patients admitted to the medical and surgical intensive care unit for the first time were evaluated. The significances of the SOFA score, maximum lactate, and lactate-albumin difference values in predicting mortality were analyzed, and cutoff values are determined.

Results: Non-survivors had higher lactate, higher lactate - albumin difference, and lower albumin values than survivors (p<0.001, for all). In surgical intensive care units, lactate, lactate - albumin difference, length of hospital and intensive care unit stays were higher, but 30– and 90– day mortalities were lower than medical intensive care units. SOFA scores were similar (p=0.30). The area under the receiver operating characteristic curve (AUC) of SOFA score (AUC = 0.776, 95% CI: 0.735–0.817) and the cutoff value were greater in the surgical intensive care unit than the medical one (AUC=0.762, 95% CI: 0.745– 0.780). The AUC of overall lactate - albumin difference (AUC=0.713, 95% CI: 0.695–0.731) was larger than overall maximum lactate (AUC=0.680, 95% CI: 0.662– 0.699) on the first day. Both the maximum lactate and lactate - albumin difference cutoff values were higher in the surgical intensive care unit.

Conclusion: Lactate - albumin difference's predictor value of mortality was superior to initial minimum albumin and maximum lactate values. Different cutoff values of the SOFA score, lactate - albumin difference, and maximum lactate should be used in medical and surgical intensive care units.

IS THERE A ROLE FOR PROBIOTICS IN THE TREATMENT OF METABOLIC SYNDROME?

81-89

Ezgi Bellikci Koyu, Zehra Büyüktuncer

REVIEW Nobel Med 2021; 17(2): 81-89

THE USE OF KITCHEN PICTURE TEST IN ALZHEIMER'S PATIENTS; A TEST DEVELOPED TO EVALUATE JUDGMENT SKILLS

90-98

Sevinç Kırıcı, Gülbahar Baştuğ, Erguvan Tuğba Özel Kızıl

RESEARCH ARTICLE Nobel Med 2021; 17(2): 90-98

ATTITUDES OF THE MENTAL HEALTH PROFESSIONALS TOWARDS UNMODIFIED AND MODIFIED TYPES OF ELECTROCONVULSIVE THERAPY: A TURKEY SAMPLE

99-104

Fatma Akyüz Karacan, Sevda Bağ, Murat Karacan, Semra Yılmaz, Medaim Yanık

RESEARCH ARTICLE Nobel Med 2021; 17(2): 99-104

ROLE OF DIABETES MELLITUS IN RECURRENT ISCHEMIC STROKES IN PATIENTS WITH ATRIAL FIBRILLATION

105-110

Gülçin Benbir Şenel, Birsen İnce

RESEARCH ARTICLE Nobel Med 2021; 17(2): 105-110

LACTATE–ALBUMIN DIFFERENCE IN MEDICAL AND SURGICAL INTENSIVE CARE UNITS

111-117

Pelin Corman Dinçer, Mustafa Kemal Arslantaş, Gülbin Töre Altun, Reyhan Arslantaş, Alper Kararmaz

RESEARCH ARTICLE Nobel Med 2021; 17(2): 111-117

EXAMINATION OF OCCUPATIONAL SAFETY LEVELS OF HEALTHCARE PROFESSIONALS: A UNIVERSITY HOSPITAL CASE

118-126

Aysun Yeşiltaş, İsa Gül

RESEARCH ARTICLE Nobel Med 2021; 17(2): 118-126

EVALUATION OF THE APPLICATIONS MADE TO A HEALTHY LIFE CENTER BETWEEN THE YEARS 2015-2017 IN MUĞLA

127-138

Metin Pıçakçıefe, Şeyma Ata, Raziye Ülkü Kıcalı, Muhammet Onur Vatandaş, Volkan Akkaya Mustafa Yıldız, Esra Bulut

RESEARCH ARTICLE Nobel Med 2021; 17(2): 127-138

PROF. DR. İHSAN DOĞRAMACI (1915-2010)

139-142

Zafer Öztek

A PORTRAIT Nobel Med 2021; 17(2): 139-142

LIVER AND SYSTEMIC DISEASES

05-09

Sebati Özdemir

REVIEW Nobel Med 2013; 9(2): 5-9

AGING KIDNEY: SENESCENCE OR DISEASE?

10-14

Meltem Gürsu, Rümeyza Kazancıoğlu, Savaş Öztürk

REVIEW Nobel Med 2013; 9(2): 10-14

IMPORTANCE OF HOLOTRANSCOBALAMIN (HOLOTC) MEASUREMENTS IN EARLY DIAGNOSIS OF COBALAMIN DEFICIENCY, ESPECIALLY IN PATIENTS WITH BORDERLINE VITAMIN B12 CONCENTRATIONS

15-20

Faruk Sönmezışık, Esma Sürmen Gür, Burak Asıltaş

RESEARCH ARTICLE Nobel Med 2013; 9(2): 15-20

EVALUATION OF PHYSICAL GROWTH IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER

21-25

Celalettin Koşan, Oğuzhan Sepetçigil, Atilla Çayır, Avni Kaya, Behzat Özkan

RESEARCH ARTICLE Nobel Med 2013; 9(2): 21-25

COMPARISON OF RISK INDEXES USED IN DETERMINING THE POSTOPERATIVE RESPIRATORY INSUFFICIENCY RISK

26-31

Gülsüm Kavalcı, Cavidan Arar, Alkın Çolak, Nesrin Turan, Cemil Kavalcı

RESEARCH ARTICLE Nobel Med 2013; 9(2): 26-31

THE EVALUATION OF PRENATAL AND ENVIROMENTAL RISK FACTORS IN CHILDREN WITH ASTHMA, ALLERGIC RHINITIS AND BRONCHIAL ASTHMA ABSTRACT

32-37

Mehmet İbrahim Turan, Müferet Ergüven, Mehmet Özdemir

RESEARCH ARTICLE Nobel Med 2013; 9(2): 32-37

REOPERATIONS AND MORBIDITY IN THYROID SURGERY

38-42

Serkan Teksöz, Murat Özcan, Aytül Sargan, Yusuf Bukey, Recep Özgültekin, Ateş Özyeğin

RESEARCH ARTICLE Nobel Med 2013; 9(2): 38-42

EFFECTS OF RAMADAN FASTING ON BLOOD PRESSURE CONTROL, LIPID PROFILE, BRAIN NATRIURETIC PEPTIDE, RENAL FUNCTIONS AND ELECTROLYTE LEVELS IN HYPERTENSIVE PATIENTS TAKING COMBINATION THERAPY

43-46

İbrahim Faruk Aktürk, İsmail Bıyık, Cüneyt Koşaş, Ahmet Arif Yalçın, Mehmet Ertürk, Fatih Uzun

RESEARCH ARTICLE Nobel Med 2013; 9(2): 43-46

MANAGEMENT OF A LARGE OUTBREAK CAUSED BY NOROVIRUS AND CAMPYLOBACTER JEJUNI OCCURRED IN A RURAL AREA IN TURKEY

47-51

İbak Gönen

RESEARCH ARTICLE Nobel Med 2013; 9(2): 47-51

FREQUENT CD99 AND FLI-1 EXPRESSIONS IN DIFFUSE LARGE B-CELL LYMPHOMA AND THEIR ASSOCIATION WITH PROLIFERATIVE AND APOPTOTIC RATES

52-56

Ufuk Berber, İsmail Yılmaz, Tolga Tuncel, Zafer Küçükodacı Aptullah Haholu

RESEARCH ARTICLE Nobel Med 2013; 9(2): 52-56
  • Pubmed Style
    Pelin Corman Dinçer, Mustafa Kemal Arslantaş, Gülbin Töre Altun, Reyhan Arslantaş, Alper Kararmaz. [LACTATE–ALBUMIN DIFFERENCE IN MEDICAL AND SURGICAL INTENSIVE CARE UNITS]. Nobel Med 2021; 17(2): 111-117, English.
  • Web Style
    Pelin Corman Dinçer, Mustafa Kemal Arslantaş, Gülbin Töre Altun, Reyhan Arslantaş, Alper Kararmaz. [LACTATE–ALBUMIN DIFFERENCE IN MEDICAL AND SURGICAL INTENSIVE CARE UNITS]. www.nobelmedicus.com/en/Article.aspx?m=1716 [Access: Mayıs 24, 2021], English.
  • AMA (American Medical Association) Style
    Pelin Corman Dinçer, Mustafa Kemal Arslantaş, Gülbin Töre Altun, Reyhan Arslantaş, Alper Kararmaz. [LACTATE–ALBUMIN DIFFERENCE IN MEDICAL AND SURGICAL INTENSIVE CARE UNITS]. Nobel Med 2021; 17(2): 111-117, English.
  • Vancouver/ICMJE Style
    Pelin Corman Dinçer, Mustafa Kemal Arslantaş, Gülbin Töre Altun, Reyhan Arslantaş, Alper Kararmaz. [LACTATE–ALBUMIN DIFFERENCE IN MEDICAL AND SURGICAL INTENSIVE CARE UNITS]. Nobel Med (2021); 17(2): 111-117, [cited Mayıs 24, 2021], English.
  • Harvard Style
    Pelin Corman Dinçer, Mustafa Kemal Arslantaş, Gülbin Töre Altun, Reyhan Arslantaş, Alper Kararmaz. (2021) [LACTATE–ALBUMIN DIFFERENCE IN MEDICAL AND SURGICAL INTENSIVE CARE UNITS]. Nobel Med, 17(2): 111-117, English.